Vardi, M., & Levy, A. P. (2012). Is it time to screen for the Haptoglobin genotype to assess the cardiovascular risk profile and vitamin E therapy responsiveness in patients with diabetes?
Citação norma ChicagoVardi, Moshe, and Andrew P. Levy. Is It Time to Screen for the Haptoglobin Genotype to Assess the Cardiovascular Risk Profile and Vitamin E Therapy Responsiveness in Patients With Diabetes? 2012.
ציטוט MLAVardi, Moshe, and Andrew P. Levy. Is It Time to Screen for the Haptoglobin Genotype to Assess the Cardiovascular Risk Profile and Vitamin E Therapy Responsiveness in Patients With Diabetes? 2012.
אזהרה: ציטוטים אלה לעיתים לא מדויקים ב 100%.